Enhanced snoMEN Vectors Facilitate Institution of GFP-HIF-1α Protein Substitute Human Cell Traces.
The snoMEN (snoRNA Modulator of gene ExpressioN) vector expertise was developed from a human field C/D snoRNA, HBII-180C, which accommodates an inside sequence that may be manipulated to make it complementary to RNA targets, permitting knock-down of focused genes. Right here we’ve got screened further human nucleolar snoRNAs and assessed their software for gene particular knock-downs to enhance the effectivity of snoMEN vectors.
We establish and characterise a brand new snoMEN vector, termed 47snoMEN, that’s derived from field C/D snoRNA U47, demonstrating its use for knock-down of each endogenous mobile proteins and G/YFP-fusion proteins.
Utilizing multiplex 47snoMEM vectors that co-express a number of 47snoMEN in a single transcript, every of which may goal totally different websites in the identical mRNA, we doc >3-fold improve in knock-down effectivity when put next with the unique HBII-180C primarily based snoMEN.
The multiplex 47snoMEM vector allowed the development of human protein alternative cell traces with improved effectivity, together with the institution of novel GFP-HIF-1α alternative cells.
Quantitative mass spectrometry evaluation confirmed the improved effectivity and specificity of protein alternative utilizing the 47snoMEN-PR vectors. The 47snoMEN vectors develop the potential purposes for snoMEN expertise in gene expression research, goal validation and gene remedy
gfpvector
NACC1 Protein Vector (Human) (pPB-C-His) |
|||
| PV103486 | ABM | 500 ng | EUR 662.4 |
NACC1 Protein Vector (Human) (pPB-N-His) |
|||
| PV103487 | ABM | 500 ng | EUR 662.4 |
NACC1 Protein Vector (Human) (pPM-C-His) |
|||
| PV103489 | ABM | 500 ng | EUR 662.4 |
NACC2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV697081 | ABM | 1.0 ug DNA | EUR 818.4 |
NACC2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV697085 | ABM | 1.0 ug DNA | EUR 818.4 |
NACC2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV697086 | ABM | 1.0 ug DNA | EUR 818.4 |
Nacc1 ORF Vector (Rat) (pORF) |
|||
| ORF071065 | ABM | 1.0 ug DNA | EUR 607.2 |
NACC2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV697082 | ABM | 1.0 ug DNA | EUR 818.4 |
Nacc1 ORF Vector (Mouse) (pORF) |
|||
| ORF050990 | ABM | 1.0 ug DNA | EUR 607.2 |
NACC2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV697083 | ABM | 1.0 ug DNA | EUR 888 |
NACC2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV697084 | ABM | 1.0 ug DNA | EUR 888 |
NACC1 sgRNA CRISPR Lentivector set (Human) |
|||
| K1386401 | ABM | 3 x 1.0 ug | EUR 406.8 |
Nacc1/ Rat Nacc1 ELISA Kit |
|||
| ELI-37475r | Lifescience Market | 96 Tests | EUR 1063.2 |
NACC1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1386402 | ABM | 1.0 ug DNA | EUR 184.8 |
NACC1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1386403 | ABM | 1.0 ug DNA | EUR 184.8 |
NACC1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1386404 | ABM | 1.0 ug DNA | EUR 184.8 |
Human NACC1 shRNA Plasmid |
|||
| 20-abx964300 | Abbexa |
|
|
NACC1 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV284260 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPB-C-His) |
|||
| PV284258 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPB-N-His) |
|||
| PV284259 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Rat) (pPM-C-His) |
|||
| PV284261 | ABM | 500 ng | EUR 723.6 |
NACC1 Recombinant Protein (Human) |
|||
| RP077613 | ABM | 100 ug | Ask for price |
NACC1 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV203960 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV203958 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV203959 | ABM | 500 ng | EUR 723.6 |
NACC1 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV203961 | ABM | 500 ng | EUR 723.6 |
NACC1 siRNA |
|||
| 20-abx903454 | Abbexa |
|
|
NACC1 siRNA |
|||
| 20-abx925337 | Abbexa |
|
|
NACC1 siRNA |
|||
| 20-abx925338 | Abbexa |
|
|
NACC1 Antibody |
|||
| BF0187 | Affbiotech | 200ul | EUR 540 |
NACC1 Antibody |
|||
| 48470-100ul | SAB | 100ul | EUR 399.6 |
NACC1 Antibody |
|||
| 48470-50ul | SAB | 50ul | EUR 286.8 |
NACC1 Antibody |
|||
| CSB-PA283286- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against NACC1. Recognizes NACC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
NACC1 Antibody |
|||
| CSB-PA283286-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against NACC1. Recognizes NACC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1386405 | ABM | 3 x 1.0 ug | EUR 451.2 |
Nacc1 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7051401 | ABM | 3 x 1.0 ug | EUR 406.8 |
NACC1 Rabbit pAb |
|||
| A11709-100ul | Abclonal | 100 ul | EUR 369.6 |
NACC1 Rabbit pAb |
|||
| A11709-200ul | Abclonal | 200 ul | EUR 550.8 |
NACC1 Rabbit pAb |
|||
| A11709-20ul | Abclonal | 20 ul | EUR 219.6 |
NACC1 Rabbit pAb |
|||
| A11709-50ul | Abclonal | 50 ul | EUR 267.6 |
NACC1 Rabbit pAb |
|||
| A11720-100ul | Abclonal | 100 ul | EUR 369.6 |
NACC1 Rabbit pAb |
|||
| A11720-200ul | Abclonal | 200 ul | EUR 550.8 |
NACC1 Rabbit pAb |
|||
| A11720-20ul | Abclonal | 20 ul | EUR 219.6 |
NACC1 Rabbit pAb |
|||
| A11720-50ul | Abclonal | 50 ul | EUR 267.6 |
Nacc1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4905601 | ABM | 3 x 1.0 ug | EUR 406.8 |
NACC1 Blocking Peptide |
|||
| BF0187-BP | Affbiotech | 1mg | EUR 234 |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1386406 | ABM | 1.0 ug DNA | EUR 200.4 |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1386407 | ABM | 1.0 ug DNA | EUR 200.4 |
NACC1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1386408 | ABM | 1.0 ug DNA | EUR 200.4 |
NACC1 Conjugated Antibody |
|||
| C48470 | SAB | 100ul | EUR 476.4 |
Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K7051402 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K7051403 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K7051404 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4905602 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4905603 | ABM | 1.0 ug DNA | EUR 184.8 |
Nacc1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4905604 | ABM | 1.0 ug DNA | EUR 184.8 |
Rat NACC1 shRNA Plasmid |
|||
| 20-abx987779 | Abbexa |
|
|
NACC1 Antibody / NAC1 / BTBD14B |
|||
| RQ6781 | NSJ Bioreagents | 100ug | EUR 356.15 |
|
Description: Nucleus accumbens-associated protein 1 is a protein that in humans is encoded by the NACC1 gene. This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. |
|||
NACC1 Antibody / Nac1 / BTBD14B |
|||
| V9183-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
|
Description: The BTB (broad-complex, tramtrack and bric a brac) domain, also known as the POZ (poxvirus and zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homo-oligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis. |
|||
NACC1 Antibody / Nac1 / BTBD14B |
|||
| V9183-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
|
Description: The BTB (broad-complex, tramtrack and bric a brac) domain, also known as the POZ (poxvirus and zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homo-oligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis. |
|||
NACC1 Antibody / Nac1 / BTBD14B |
|||
| V9183SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
|
Description: The BTB (broad-complex, tramtrack and bric a brac) domain, also known as the POZ (poxvirus and zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. BTBD14B (BTB/POZ domain-containing protein 14B), also known as NACC1 (nucleus accumbens associated 1), BEND8 or NAC1, is a 527 amino acid protein that localizes to both the nucleus and the cytoplasm and contains one BTB (POZ) domain. Existing as a homo-oligomer that interacts with HDAC3 and HDAC4, BTBD14B functions as a transcriptional repressor that influences the transcriptional activity of CRIF1 and is required for proteasome recruitment to the nucleus and cytoplasm in dendritic spines. BTBD14B is overexpressed in multiple carcinomas, suggesting a role in tumor development and metastasis. |
|||
Mouse NACC1 shRNA Plasmid |
|||
| 20-abx975804 | Abbexa |
|
|
NACC1 Recombinant Protein (Rat) |
|||
| RP213191 | ABM | 100 ug | Ask for price |
NACC1 Recombinant Protein (Mouse) |
|||
| RP152966 | ABM | 100 ug | Ask for price |
Polyclonal NACC1 Antibody (Center) |
|||
| APR04758G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NACC1 (Center). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NACC1 Antibody (C-term) |
|||
| APR04778G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NACC1 (C-term). This antibody is tested and proven to work in the following applications: |
|||
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K7051405 | ABM | 3 x 1.0 ug | EUR 451.2 |
Human Nucleus accumbens- associated protein 1, NACC1 ELISA KIT |
|||
| ELI-16141h | Lifescience Market | 96 Tests | EUR 988.8 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K4905605 | ABM | 3 x 1.0 ug | EUR 451.2 |
NACC2 ORF Vector (Human) (pORF) |
|||
| ORF025873 | ABM | 1.0 ug DNA | EUR 486 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K7051406 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K7051407 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K7051408 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K4905606 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K4905607 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K4905608 | ABM | 1.0 ug DNA | EUR 200.4 |
Nacc1 3'UTR GFP Stable Cell Line |
|||
| TU163804 | ABM | 1.0 ml | Ask for price |
NACC1 3'UTR GFP Stable Cell Line |
|||
| TU065180 | ABM | 1.0 ml | EUR 1825.2 |
Nacc1 3'UTR GFP Stable Cell Line |
|||
| TU263713 | ABM | 1.0 ml | Ask for price |
Nucleus Accumbens Associated 1 (NACC1) Antibody |
|||
| abx330473-100ul | Abbexa | 100 ul | EUR 510 |
A replicating plasmid-based vector for GFP expression in Mycoplasma hyopneumoniae.
Mycoplasma hyopneumoniae (M. hyopneumoniae) causes porcine enzootic pneumonia (PEP) that considerably impacts the pig trade worldwide. Regardless of the provision of the entire genome sequence, research on the pathogenesis of this organism have been restricted as a result of lack of a genetic manipulation system.
Subsequently, the intention of the present examine was to generate a common GFP reporter vector primarily based on a replicating plasmid. Right here, we describe the feasibility of GFP reporter expression in M. hyopneumoniae (pressure 168L) managed by the p97 gene promoter of this mycoplasma. An expression plasmid (pMD18-TOgfp) containing the p97 gene promoter, and origin of replication (oriC) of M. hyopneumoniae, tetracycline resistant marker (tetM), and GFP was constructed and used to rework competent M. hyopneumoniae cells.
We noticed inexperienced fluorescence in M. hyopneumoniae transformants beneath fluorescence microscopy, which signifies that there was expression of the GFP reporter that was pushed by the p97 gene promoter.
Moreover, an electroporation methodology for M. hyopneumoniae with an effectivity of roughly 1 x 10(-6) transformants/μg plasmid DNA was optimized and is described herein. In conclusion, our information display the susceptibility of M. hyopneumoniae to genetic manipulation whereby overseas genes are expressed. This work might encourage the event of genetic instruments to govern the genome of M. hyopneumoniae for practical genomic analyses.
Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: evaluation of immunophenotype and differentiation capability in vitro.
Adipose derived mesenchymal stromal/stem cells (ASCs) are a heterogeneous inhabitants characterised by (a) their potential to stick to plastic; (b) immunophenotypic expression of sure cell floor markers, whereas missing others; and (c) the capability to distinguish into lineages of mesodermal origin together with osteocytes, chondrocytes and adipocytes. The long-term objective is to make the most of these cells for medical translation into cell-based therapies. Nonetheless, preclinical security and efficacy have to be demonstrated in animal fashions.
ASCs will also be utilized as organic autos for vector-based gene supply techniques, since they’re believed to dwelling to websites of irritation and an infection in vivo. These elements motivated the event of a labelling system for ASCs utilizing lentiviral vector-based inexperienced fluorescent protein (GFP) transduction. Human ASCs had been transduced with GFP-expressing lentiviral vectors. A titration examine decided the viral titer required to transduce the utmost variety of ASCs.
The impact of the transduced GFP lentiviral vector on ASC immunophenotypic expression of floor markers in addition to their potential to distinguish into osteocytes and adipocytes had been assessed in vitro.
Transduction effectivity in ASC cultures of roughly 80 % was noticed with an MOI of ~118. No important immunophenotypic variations had been noticed between transduced and non-transduced cells and each cell sorts efficiently differentiated into adipocytes and osteocytes in vitro. We obtained >80 % transduction of ASCs utilizing GFP lentiviral vectors.
Transduced ASCs maintained plastic adherence, demonstrated ASC immunophenotype and the flexibility to distinguish into cells of the mesodermal lineage. This GFP-ASC transduction approach provides a possible monitoring system for future pre-clinical research.
100G Acrylamide |
|||
| NAT1014 | National Diagnostics | 100G | EUR 120 |
500G Acrylamide |
|||
| NAT1016 | National Diagnostics | 500G | EUR 261.6 |
1KG Acrylamide |
|||
| NAT1018 | National Diagnostics | 1KG | EUR 412.8 |
25G AquaPor LE |
|||
| NAT1020 | National Diagnostics | 25G | EUR 132 |
100G AquaPor LE GTAC |
|||
| NAT1022 | National Diagnostics | 100G | EUR 250.8 |
500G AquaPor LE GTAC |
|||
| NAT1024 | National Diagnostics | 500G | EUR 878.4 |
25G AquaPor ES |
|||
| NAT1026 | National Diagnostics | 25G | EUR 152.4 |
100G AquaPor ES |
|||
| NAT1028 | National Diagnostics | 100G | EUR 350.4 |
25G AquaPor LM |
|||
| NAT1030 | National Diagnostics | 25G | EUR 288 |
100G AquaPor LM |
|||
| NAT1032 | National Diagnostics | 100G | EUR 860.4 |
25G AquaPor HR |
|||
| NAT1034 | National Diagnostics | 25G | EUR 236.4 |
100G AquaPor HR |
|||
| NAT1036 | National Diagnostics | 100G | EUR 592.8 |
25G AquaPor 3:1 |
|||
| NAT1038 | National Diagnostics | 25G | EUR 250.8 |
100G AquaPor 3:1 |
|||
| NAT1040 | National Diagnostics | 100G | EUR 570 |
25G Bis (Methylene Bis-Acrylamide) |
|||
| NAT1042 | National Diagnostics | 25G | EUR 100.8 |
25G DATD Ultrapure |
|||
| NAT1044 | National Diagnostics | 25G | EUR 168 |
250G Glycine |
|||
| NAT1046 | National Diagnostics | 250G | EUR 94.8 |
1KG Glycine Ultrapure |
|||
| NAT1048 | National Diagnostics | 1KG | EUR 128.4 |
250G Tris |
|||
| NAT1050 | National Diagnostics | 250G | EUR 102 |
1KG Tris Ultrapure |
|||
| NAT1052 | National Diagnostics | 1KG | EUR 177.6 |
100G Tricine |
|||
| NAT1054 | National Diagnostics | 100G | EUR 120 |
100G Ion Exchange Resin (mixed bed) |
|||
| NAT1056 | National Diagnostics | 100G | EUR 96 |
25G Riboflavin |
|||
| NAT1058 | National Diagnostics | 25G | EUR 96 |
25ML TEMED |
|||
| NAT1060 | National Diagnostics | 25ML | EUR 99.6 |
25G Ammonium Persulfate |
|||
| NAT1062 | National Diagnostics | 25G | EUR 96 |
100G Ammonium Persulfate |
|||
| NAT1064 | National Diagnostics | 100G | EUR 118.8 |
1G Dithiothreitol (DTT) |
|||
| NAT1066 | National Diagnostics | 1G | EUR 103.2 |
5G Dithiothreitol (DTT) |
|||
| NAT1068 | National Diagnostics | 5G | EUR 183.6 |
50ML 2-Mercaptoethanol |
|||
| NAT1070 | National Diagnostics | 50ML | EUR 112.8 |
100G SDS Ultrapure |
|||
| NAT1072 | National Diagnostics | 100G | EUR 111.6 |
1KG SDS Ultrapure |
|||
| NAT1074 | National Diagnostics | 1KG | EUR 457.2 |
250G Urea |
|||
| NAT1076 | National Diagnostics | 250G | EUR 98.4 |
1KG Urea |
|||
| NAT1078 | National Diagnostics | 1KG | EUR 138 |
450ML Glycerol Ultrapure |
|||
| NAT1080 | National Diagnostics | 450ML | EUR 132 |
200ML Tween 20 Ultrapure |
|||
| NAT1082 | National Diagnostics | 200ML | EUR 132 |
1L Tween 20 |
|||
| NAT1084 | National Diagnostics | 1L | EUR 169.2 |
200ML Formamide |
|||
| NAT1086 | National Diagnostics | 200ML | EUR 111.6 |
500ML Boric Acid |
|||
| NAT1088 | National Diagnostics | 500ML | EUR 103.2 |
100G EDTA |
|||
| NAT1090 | National Diagnostics | 100G | EUR 94.8 |
500G EDTA |
|||
| NAT1092 | National Diagnostics | 500G | EUR 177.6 |
GelDry Film 11 X 12 cm |
|||
| NAT1094 | National Diagnostics | PK50 | EUR 100.8 |
25ML Formamide CE |
|||
| NAT1096 | National Diagnostics | 25ML | Ask for price |
25ML Glass Bond |
|||
| NAT1098 | National Diagnostics | 25ML | EUR 158.4 |
450ML Glass Free |
|||
| NAT1100 | National Diagnostics | 450ML | EUR 196.8 |
GelDry Film 22.5 X 22.5 cm |
|||
| NAT1102 | National Diagnostics | PK50 | EUR 130.8 |
1L DEPC Treated Water |
|||
| NAT1104 | National Diagnostics | 1L | EUR 120 |
Sterling Rapid Silver Stain Kit |
|||
| NAT1106 | National Diagnostics | 1KIT | EUR 265.2 |
1L ProtoBlue Safe |
|||
| NAT1108 | National Diagnostics | 1L | EUR 159.6 |
4L ProtoBlue Safe |
|||
| NAT1110 | National Diagnostics | 4L | EUR 282 |
1L ProtoStain Blue |
|||
| NAT1112 | National Diagnostics | 1L | EUR 164.4 |
25ML Nuclistain |
|||
| NAT1114 | National Diagnostics | 25ML | EUR 128.4 |
450ML AcrylaGel 30% |
|||
| NAT1116 | National Diagnostics | 450ML | EUR 128.4 |
1L AcrylaGel 30% |
|||
| NAT1118 | National Diagnostics | 1L | EUR 177.6 |
450ML Bis-AcrylaGel 2% |
|||
| NAT1120 | National Diagnostics | 450ML | EUR 98.4 |
1L Bis-AcrylaGel 2% |
|||
| NAT1122 | National Diagnostics | 1L | EUR 111.6 |
450ML UreaGel 29:1 Concentrate |
|||
| NAT1124 | National Diagnostics | 450ML | EUR 133.2 |
1L UreaGel 29:1 Concentrate |
|||
| NAT1126 | National Diagnostics | 1L | EUR 183.6 |
UreaGel 29:1 System 1L Kit |
|||
| NAT1128 | National Diagnostics | EACH | EUR 171.6 |
UreaGel 29:1 System 2.2L Kit |
|||
| NAT1130 | National Diagnostics | EACH | EUR 253.2 |
450ML SequaGel UreaGel Concentrate |
|||
| NAT1132 | National Diagnostics | 450ML | EUR 126 |
1L SequaGel UreaGel Concentrate |
|||
| NAT1134 | National Diagnostics | 1L | EUR 160.8 |
SequaGel Sequencing System 1L Kit |
|||
| NAT1136 | National Diagnostics | 1KIT | EUR 171.6 |
SequaGel Sequencing System 2.2L Kit |
|||
| NAT1138 | National Diagnostics | EACH | EUR 253.2 |
100ML SequaGel Buffer |
|||
| NAT1140 | National Diagnostics | 100ML | EUR 80.4 |
200ML SequaGel UreaGel Buffer |
|||
| NAT1142 | National Diagnostics | 200ML | EUR 84 |
450ML SequaGel UreaGel-6 |
|||
| NAT1144 | National Diagnostics | 450ML | EUR 115.2 |
1L SequaGel UreaGel-6 |
|||
| NAT1146 | National Diagnostics | 1L | EUR 151.2 |
450ML SequaGel UreaGel-8 |
|||
| NAT1148 | National Diagnostics | 450ML | EUR 115.2 |
1L SequaGel UreaGel-8 |
|||
| NAT1150 | National Diagnostics | 1L | EUR 151.2 |
450ML SequaGel UreaGel Diluent |
|||
| NAT1152 | National Diagnostics | 450ML | EUR 90 |
1L SequaGel UreaGel Diluent |
|||
| NAT1154 | National Diagnostics | 1L | EUR 103.2 |
90ML SequaGel Complete Buffer |
|||
| NAT1156 | National Diagnostics | 90ML | EUR 79.2 |
200ML SequaGel UreaGel Complete Buffer |
|||
| NAT1158 | National Diagnostics | 200ML | EUR 85.2 |
450ML SequaGel XR |
|||
| NAT1160 | National Diagnostics | 450ML | EUR 126 |
1L SequaGel XR |
|||
| NAT1162 | National Diagnostics | 1L | EUR 165.6 |
100ML SequaGel XR Concentrate |
|||
| NAT1164 | National Diagnostics | 100ML | EUR 128.4 |
450ML SequaGel XR Concentrate |
|||
| NAT1166 | National Diagnostics | 450ML | EUR 361.2 |
200ML SequaGel MD Monomer Solution |
|||
| NAT1168 | National Diagnostics | 200ML | EUR 220.8 |
SequaGel MD SSCP Kit |
|||
| NAT1170 | National Diagnostics | 1KIT | EUR 253.2 |
SequaGel MD Heteroduplex Kit |
|||
| NAT1172 | National Diagnostics | EACH | EUR 265.2 |
1.2ML SequaGel MD SSCP Stop Solution |
|||
| NAT1174 | National Diagnostics | 1.2ML | EUR 85.2 |
450ML AccuGel 19:1 (30%) |
|||
| NAT1176 | National Diagnostics | 450ML | EUR 126 |
1L AccuGel 19:1 (30%) |
|||
| NAT1178 | National Diagnostics | 1L | EUR 165.6 |
450ML AccuGel 19:1 (40%) |
|||
| NAT1180 | National Diagnostics | 450ML | EUR 130.8 |
1L AccuGel 19:1 (40%) |
|||
| NAT1182 | National Diagnostics | 1L | EUR 168 |
450ML AccuGel 29:1 (30%) |
|||
| NAT1184 | National Diagnostics | 450ML | EUR 126 |